Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP)
- 1 August 2017
- journal article
- practice guideline
- Published by Elsevier in Digestive and Liver Disease
- Vol. 49 (8) , 831-840
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2014
- Signature patterns of human papillomavirus type 16 in invasive anal carcinomaHuman Pathology, 2013
- Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage LevelsJNCI: Journal of the National Cancer Institute, 2013
- Incidence of HIV-Related Anal Cancer Remains Increased Despite Long-Term Combined Antiretroviral Treatment: Results From the French Hospital Database on HIVJournal of Clinical Oncology, 2012
- Human papillomavirus genotype distribution in anal cancer in France: The EDiTH V studyInternational Journal of Cancer, 2010
- Epidermoid anal cancer prognosis comparison among HIV+ and HIV− patientsAlimentary Pharmacology & Therapeutics, 2009
- Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal CanalJAMA, 2008
- Human papillomavirus, smoking, and sexual practices in the etiology of anal cancerCancer, 2004
- Human Papillomavirus-Associated Cancers in Patients With Human Immunodeficiency Virus Infection and Acquired Immunodeficiency SyndromeJNCI: Journal of the National Cancer Institute, 2000
- Cancers of the anogenital region in renal transplant recipients: Analysis of 65 casesCancer, 1986